Assignee
PHOENIX MOLECULAR DESIGNS
CA·4 granted patents·1 pending application·15 citations·filing 2017–2020
Top patents by PatentIndex Score
5 records- 0192US9771366B2Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2017·Granted Sep 26, 2017·11 cites·20 claims
- 0286US10081632B2Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2017·Granted Sep 25, 2018·3 cites·17 claims
- 0375US10758530B2Carboxamide derivatives useful as rsk inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2017·Granted Sep 1, 2020·1 cites·19 claims
- 0465US2021186961A1Carboxamide derivatives useful as rsk inhibitorsPHOENIX MOLECULAR DESIGNS·Filed 2020·Application pending·0 cites
- 0540US12378245B2Crystalline forms of an RSK inhibitorPHOENIX MOLECULAR DESIGNS·Filed 2020·Granted Aug 5, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when PHOENIX MOLECULAR DESIGNS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →